| |
| |
|
| Insider
Information: |
Tyree James L |
| Relationship: |
Director |
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
286,780 |
|
|
Indirect Shares
|
1,199 |
|
|
| Direct
Value |
$15,368,048 |
|
|
|
Indirect Value
|
$128,928 |
|
|
| Total
Shares |
287,979 |
|
|
| Total
Value |
$15,496,976 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -75.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
Executive Vice President |
2009-02-27 |
132,176 |
2009-02-27 |
1,199 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2017-04-20 |
70,554 |
2014-06-02 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-10-20 |
0 |
2015-05-22 |
0 |
Premium* |
|
|
Assertio Holdings Inc |
ASRT |
Director |
2019-05-08 |
80,590 |
2019-05-07 |
0 |
Premium* |
|
|
Genelux Corp |
GNLX |
Director |
2023-12-13 |
3,460 |
2023-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABT |
Abbott Laboratories |
Senior Vice PresidentOfficer |
• – – |
2005-04-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
52,503 |
|
- |
|
| ABT |
Abbott Laboratories |
Senior Vice PresidentOfficer |
• – – |
2005-04-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,087 |
|
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2006-05-01 |
4 |
S |
$43.01 |
$5,892 |
D/D |
(137) |
93,532 |
|
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2006-07-26 |
4 |
S |
$47.50 |
$15,200 |
D/D |
(320) |
90,406 |
|
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2006-05-01 |
4 |
D |
$42.60 |
$17,166 |
D/D |
(403) |
93,669 |
|
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2006-02-21 |
4 |
S |
$43.70 |
$20,014 |
D/D |
(458) |
94,072 |
|
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2006-02-18 |
4 |
D |
$44.15 |
$22,561 |
D/D |
(511) |
94,530 |
|
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-05-01 |
4 |
D |
$52.75 |
$28,432 |
D/D |
(539) |
117,477 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-05-01 |
4 |
D |
$56.62 |
$30,575 |
D/D |
(540) |
119,930 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-18 |
4 |
D |
$52.49 |
$35,851 |
D/D |
(683) |
118,836 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-18 |
4 |
D |
$55.55 |
$37,996 |
D/D |
(684) |
144,405 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-08-27 |
4 |
D |
$57.57 |
$40,932 |
D/D |
(711) |
121,247 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2016-05-18 |
4 |
AS |
$10.47 |
$8,512 |
D/D |
(813) |
50,697 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-19 |
4 |
S |
$56.08 |
$49,577 |
D/D |
(884) |
143,521 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-11-14 |
4 |
D |
$57.14 |
$52,055 |
D/D |
(911) |
121,376 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-11-14 |
4 |
OE |
$45.45 |
$47,267 |
D/D |
1,040 |
122,287 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-15 |
4 |
S |
$52.83 |
$79,245 |
D/D |
(1,500) |
85,605 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2007-02-20 |
4 |
D |
$52.49 |
$93,222 |
D/D |
(1,776) |
117,060 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2015-06-02 |
4 |
AS |
$16.85 |
$41,080 |
D/D |
(2,438) |
33,182 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2021-05-21 |
4 |
AS |
$9.76 |
$23,956 |
D/D |
(2,454) |
15,275 |
0 |
% |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-29 |
4 |
D |
$54.22 |
$145,472 |
D/D |
(2,683) |
142,750 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2006-07-01 |
4 |
D |
$43.18 |
$121,163 |
D/D |
(2,806) |
90,726 |
|
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2008-02-17 |
4 |
D |
$55.55 |
$167,705 |
D/D |
(3,019) |
145,089 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2009-02-17 |
4 |
D |
$54.94 |
$179,544 |
D/D |
(3,268) |
109,208 |
0 |
- |
|
| GNLX |
Genelux Corp |
Director |
– • – |
2023-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,460 |
12,460 |
0 |
- |
|
89 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
